Biotech

All Articles

Eli Lilly hops deeper in to AI along with $409M Hereditary Surge offer

.Eli Lilly has risen in to an AI-enabled medicine breakthrough offer, partnering with RNA expert Her...

After FDA denial as well as cutbacks, Lykos CEO is leaving behind

.Lykos CEO as well as creator Amy Emerson is quiting, with chief working officer Michael Mullette ta...

Novartis sparks brand-new phase of Voyager treaty with $15M capsid deal

.Novartis is opening a brand new frontier in its own cooperation with Voyager Therapies, paying $15 ...

Lilly blog posts even more positive information on its regular insulin prospect

.On the heels of an FDA denial for its own main competing Novo Nordisk, Eli Lilly is pulling ahead i...

IN 8bio halts phase 2 trial, gives up half of staff

.Only a couple of months after application the very first patient in a stage 2 trial for recently id...

Lilly, Haya ink $1B biobuck weight problems deal to explore dark genome

.Eli Lilly's look for weight problems targets has actually led it to the darker genome. The Big Phar...

ArsenalBio elevates $325M, pivots off of previous lead resource

.Collection Biosciences is going on up. The cell therapy provider has added $325 thousand in ammo al...

Lilly- backed weight reduction biotech data IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has actually fil...

Aelis' cannabis make use of medication fails period 2b, steering Indivior to reassess $100M choice

.Aelis Farma's hopes of safeguarding a simple, favorable choice on a $one hundred million choice rem...

ProKidney halts stage 3 trial certainly not needed for tissue therapy permission

.ProKidney has actually ceased among a pair of period 3 trials for its tissue treatment for kidney d...